leisure time -WSS

leisure time

author：explore 2025-10-02 02:02:25 Page View：868

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sanders adds drug shortage policies to pandemic preparedness bill
Next article： Anesthesiologist group: stop taking Ozempic before surgery

explore

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

AdobeThisarticleisadaptedfromthe2023editionofSTAT’sannualreport,“Rankingbiotech’stopventurecapitalfi

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

Medicare to cover more brain scans for Alzheimer’s patients

AnewlyapprovedAlzheimer’sdrugmadebyEisaiandBiogen,calledLeqembi,aimstoclearoutamyloidplaquesinpatien